Anbieter: HPB-Red, Dallas, TX, USA
Hardcover. Zustand: Good. Connecting readers with great books since 1972! Used textbooks may not include companion materials such as access codes, etc. May have some wear or writing/highlighting. We ship orders daily and Customer Service is our top priority!
Anbieter: ThriftBooks-Atlanta, AUSTELL, GA, USA
Hardcover. Zustand: Very Good. No Jacket. May have limited writing in cover pages. Pages are unmarked. ~ ThriftBooks: Read More, Spend Less.
Anbieter: ThriftBooks-Dallas, Dallas, TX, USA
Hardcover. Zustand: Very Good. No Jacket. May have limited writing in cover pages. Pages are unmarked. ~ ThriftBooks: Read More, Spend Less.
Anbieter: ThriftBooks-Atlanta, AUSTELL, GA, USA
Hardcover. Zustand: As New. No Jacket. Pages are clean and are not marred by notes or folds of any kind. ~ ThriftBooks: Read More, Spend Less.
Anbieter: HPB-Emerald, Dallas, TX, USA
Hardcover. Zustand: Good. Connecting readers with great books since 1972! Used books may not include companion materials, and may have some shelf wear or limited writing. We ship orders daily and Customer Service is our top priority!
Anbieter: suffolkbooks, Center moriches, NY, USA
hardcover. Zustand: Very Good. Fast Shipping - Safe and Secure 7 days a week!
Zustand: As New. Unread book in perfect condition.
Zustand: New.
Anbieter: medimops, Berlin, Deutschland
Zustand: good. Befriedigend/Good: Durchschnittlich erhaltenes Buch bzw. Schutzumschlag mit Gebrauchsspuren, aber vollständigen Seiten. / Describes the average WORN book or dust jacket that has all the pages present.
Softcover. Zustand: As New. Like new. Immediately dispatched from Germany.
Sprache: Englisch
Verlag: Berlin/ Heidelberg, Springer Berlin., 2012
ISBN 10: 3642261434 ISBN 13: 9783642261435
Anbieter: Universitätsbuchhandlung Herta Hold GmbH, Berlin, Deutschland
2010. 16 x 24 cm. XIV, 231 S. XIV, 231 p. Versand aus Deutschland / We dispatch from Germany via Air Mail. Einband bestoßen, daher Mängelexemplar gestempelt, sonst sehr guter Zustand. Imperfect copy due to slightly bumped cover, apart from this in very good condition. Stamped. (Recent Results in Cancer Research). Sprache: Englisch.
Sprache: Deutsch
ISBN 10: 3836215551 ISBN 13: 9783836215558
Anbieter: medimops, Berlin, Deutschland
Zustand: good. Befriedigend/Good: Durchschnittlich erhaltenes Buch bzw. Schutzumschlag mit Gebrauchsspuren, aber vollständigen Seiten. / Describes the average WORN book or dust jacket that has all the pages present.
EUR 17,35
Anzahl: 6 verfügbar
In den WarenkorbZustand: New.
EUR 19,56
Anzahl: 6 verfügbar
In den WarenkorbZustand: As New. Unread book in perfect condition.
Anbieter: Hay-on-Wye Booksellers, Hay-on-Wye, HEREF, Vereinigtes Königreich
EUR 28,25
Anzahl: 1 verfügbar
In den WarenkorbZustand: As New.
Anbieter: Antiquariat Bookfarm, Löbnitz, Deutschland
808 Seiten Ehemaliges Bibliotheksexemplar mit Stempel und Rückensignatur. Leichte bis Moderate Lager und Gebrauchsspuren. Guter Zustand. 9783836216227 Sprache: Deutsch Gewicht in Gramm: 1461.
Sprache: Englisch
Verlag: Springer-Verlag Berlin and Heidelberg GmbH & Co. KG, Berlin, 2012
ISBN 10: 3642261434 ISBN 13: 9783642261435
Anbieter: Grand Eagle Retail, Bensenville, IL, USA
Paperback. Zustand: new. Paperback. Angiogenesis is attracting increased scientific and clinical interest. The identification of novel mediators and targeting molecules has led to significant progress in our understanding of tumor angiogenesis and tumor vessel targeting. Important advances in cancer treatment have already emerged, and in the future, blood vessel targeting will play a significant role within individualized therapeutic strategies. This volume provides a general overview of the latest developments in angiogenesis inhibition in cancer. All aspects from the bench to the bedside are considered, with detailed attention both to basic research and to its translation into clinical practice. Individual chapters are devoted to the roles of angiopoietins, HIF-1a, chemokines, PDGF and VEGF, and vascular integrins. The latest results of clinical trials are presented, and various advanced targeting strategies are discussed. This book will be invaluable to all who wish to learn of the most recent advances in this exciting field. The identification of novel mediators and targeting molecules has led to significant progress in our understanding of tumor angiogenesis and tumor vessel targeting. Important advances in cancer treatment have already emerged, and in the future, blood vessel targeting will play a significant role within individualized therapeutic strategies. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.
Anbieter: GreatBookPrices, Columbia, MD, USA
Zustand: New.
Anbieter: Lucky's Textbooks, Dallas, TX, USA
EUR 109,12
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New.
Anbieter: Hay-on-Wye Booksellers, Hay-on-Wye, HEREF, Vereinigtes Königreich
EUR 42,01
Anzahl: 1 verfügbar
In den WarenkorbZustand: As New.
Broschiert. Zustand: Gut. 141 Seiten Von 1992. Innerhalb Deutschlands Versand je nach Größe/Gewicht als Großbrief bzw. Bücher- und Warensendung mit der Post oder per DHL. Rechnung mit MwSt.-Ausweis liegt jeder Lieferung bei. Sprache: Deutsch Gewicht in Gramm: 226.
Anbieter: GreatBookPrices, Columbia, MD, USA
Zustand: As New. Unread book in perfect condition.
Anbieter: Ria Christie Collections, Uxbridge, Vereinigtes Königreich
EUR 123,95
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New. In.
Anbieter: Hay-on-Wye Booksellers, Hay-on-Wye, HEREF, Vereinigtes Königreich
EUR 75,37
Anzahl: 3 verfügbar
In den WarenkorbZustand: As New.
Anbieter: GreatBookPrices, Columbia, MD, USA
Zustand: New.
Sprache: Englisch
Verlag: Springer-Verlag Berlin and Heidelberg GmbH & Co. KG, Berlin, 2009
ISBN 10: 354078280X ISBN 13: 9783540782803
Anbieter: Grand Eagle Retail, Bensenville, IL, USA
Hardcover. Zustand: new. Hardcover. Angiogenesis is attracting increased scientific and clinical interest. The identification of novel mediators and targeting molecules has led to significant progress in our understanding of tumor angiogenesis and tumor vessel targeting. Important advances in cancer treatment have already emerged, and in the future, blood vessel targeting will play a significant role within individualized therapeutic strategies. This volume provides a general overview of the latest developments in angiogenesis inhibition in cancer. All aspects from the bench to the bedside are considered, with detailed attention both to basic research and to its translation into clinical practice. Individual chapters are devoted to the roles of angiopoietins, HIF-1a, chemokines, PDGF and VEGF, and vascular integrins. The latest results of clinical trials are presented, and various advanced targeting strategies are discussed. This book will be invaluable to all who wish to learn of the most recent advances in this exciting field. The identification of novel mediators and targeting molecules has led to significant progress in our understanding of tumor angiogenesis and tumor vessel targeting. Important advances in cancer treatment have already emerged, and in the future, blood vessel targeting will play a significant role within individualized therapeutic strategies. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.
Anbieter: Lucky's Textbooks, Dallas, TX, USA
EUR 153,66
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New.
Anbieter: GreatBookPrices, Columbia, MD, USA
Zustand: As New. Unread book in perfect condition.
Anbieter: Revaluation Books, Exeter, Vereinigtes Königreich
EUR 160,77
Anzahl: 2 verfügbar
In den WarenkorbPaperback. Zustand: Brand New. 2010 edition. 248 pages. 9.20x6.10x0.56 inches. In Stock.
Sprache: Englisch
Verlag: Springer Berlin Heidelberg, 2012
ISBN 10: 3642261434 ISBN 13: 9783642261435
Anbieter: AHA-BUCH GmbH, Einbeck, Deutschland
Taschenbuch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - Angiogenesis is attracting increased scientific and clinical interest. The identification of novel mediators and targeting molecules has led to significant progress in our understanding of tumor angiogenesis and tumor vessel targeting. Important advances in cancer treatment have already emerged, and in the future, blood vessel targeting will play a significant role within individualized therapeutic strategies. This volume provides a general overview of the latest developments in angiogenesis inhibition in cancer. All aspects from the bench to the bedside are considered, with detailed attention both to basic research and to its translation into clinical practice. Individual chapters are devoted to the roles of angiopoietins, HIF-1a, chemokines, PDGF and VEGF, and vascular integrins. The latest results of clinical trials are presented, and various advanced targeting strategies are discussed. This book will be invaluable to all who wish to learn of the most recent advances in this exciting field.